JLE

Hépato-Gastro & Oncologie Digestive

MENU

Prise en charge diagnostique et thérapeutique des sténoses bénignes des voies biliaires : la place prépondérante de l’endoscopie Volume 25, numéro 10, Décembre 2018

  • [1] Lin M.-S., Huang J.-X., Yu H. Elevated serum level of carbohydrate antigen 19-9 in benign biliary stricture diseases can reduce its value as a tumor marker. Int J Clin Exp Med. 2014;7:744-750. 3
  • [2] Joshi D., Webster G.J.M. Biliary and hepatic involvement in IgG4-related disease. Aliment Pharmacol Ther. 2014;40:1251-1261. 11–12
  • [3] Heinzow HS, Kammerer S, Rammes C, et al. Comparative analysis of ERCP, IDUS, EUS and CT in predicting malignant bile duct strictures. World J Gastroenterol 2014 ; 20 (30) : 10495-503.
  • [4] Suthar M., Purohit S., Bhargav V. Role of MRCP in differentiation of benign and malignant causes of biliary obstruction. J Clin Diagn Res JCDR. 2015;9:TC08-12. 11
  • [5] Wiersema M.J., Vilmann P., Giovannini M. Endosonography-guided fine-needle aspiration biopsy: Diagnostic accuracy and complication assessment. Gastroenterology. 1997;112:1087-1095. 4
  • [6] Tamada K., Tomiyama T., Wada S. Endoscopic transpapillary bile duct biopsy with the combination of intraductal ultrasonography in the diagnosis of biliary strictures. Gut. 2002;50:326-331. 3
  • [7] Meister T., Heinzow H.S., Woestmeyer C. Intraductal ultrasound substantiates diagnostics of bile duct strictures of uncertain etiology. World J Gastroenterol. 2013;19:874-881. 6
  • [8] Gonda T.A., Glick M.P., Sethi A. Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures. Gastrointest Endosc. 2012;75:74-79. 1
  • [9] Kipp B.R., Stadheim L.M., Halling S.A. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol. 2004;99:1675-1681. 9
  • [10] Baron T.H., Harewood G.C., Rumalla A. A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures. Clin Gastroenterol Hepatol. 2004;2:214-219. 3
  • [11] Draganov P.V., Lin T., Chauhan S. Prospective evaluation of the clinical utility of ERCP-guided cholangiopancreatoscopy with a new direct visualization system. Gastrointest Endosc. 2011;73:971-979. 5
  • [12] Laleman W, Verraes K, Van Steenbergen W, et al. Usefulness of the single-operator cholangioscopy system SpyGlass in biliary disease: A single-center prospective cohort study and aggregated review. Surg Endosc 2017 ; 31 (5) : 2223-32.
  • [13] Lübbe J, Arnelo U, Lundell L, et al. ERCP-guided cholangioscopy using a single-use system : nationwide register-based study of its use in clinical practice. Endoscopy 2015 ; 47 (9) : 802-7.
  • [14] Slivka A, Gan I, Jamidar P, et al. Validation of the diagnostic accuracy of probe-based confocal laser endomicroscopy for the characterization of indeterminate biliary strictures: Results of a prospective multicenter international study. Gastrointest Endosc 2015 ; 81 (2) : 282-90.
  • [15] Caillol F, Filoche B, Gaidhane M, et al. Refined probe-based confocal laser endomicroscopy classification for biliary strictures : the Paris Classification. Dig Dis Sci 2013; 58(6):1784-9.
  • [16] Taunk P., Singh S., Lichtenstein D. Improved classification of indeterminate biliary strictures by probe-based confocal laser endomicroscopy using the Paris Criteria following biliary stenting. J Gastroenterol Hepatol. 2017;32:1778-1783. 10
  • [17] Barkin J.A., Levy C., Souto E.O. Endoscopic management of primary sclerosing cholangitis. Ann Hepatol. 2017;16:842-850. 6
  • [18] Eum Y.O., Park J.K., Chun J. Non-surgical treatment of post-surgical bile duct injury: Clinical implications and outcomes. World J Gastroenterol. 2014;20:6924-6931. 22
  • [19] Devière J, Nageshwar Reddy D, Püspök A, et al. Successful management of benign biliary strictures with fully covered self-expanding metal stents. Gastroenterology 2014 ; 147 (2) : 385-95.
  • [20] Khan MA, Baron TH, Kamal F, et al. Efficacy of self-expandable metal stents in management of benign biliary strictures and comparison with multiple plastic stents: A meta-analysis. Endoscopy 2017 ; 49 (7) : 682-94.
  • [21] Mauri G., Michelozzi C., Melchiorre F. Benign biliary strictures refractory to standard bilioplasty treated using polydoxanone biodegradable biliary stents: Retrospective multicentric data analysis on 107 patients. Eur Radiol. 2016;26:4057-4063. 11
  • [22] Siiki A., Rinta-Kiikka I., Sand J. A pilot study of endoscopically inserted biodegradable biliary stents in the treatment of benign biliary strictures and cystic duct leaks. Gastrointest Endosc. 2018;87:1132-1137. 4
  • [23] James T.W., Fan Y.C., Baron T.H. EUS-guided hepaticoenterostomy as a portal to allow definitive antegrade treatment of benign biliary diseases in patients with surgically altered anatomy. Gastrointest Endosc. 2018;6:E735-E738. 6
  • [24] Miranda-García P., Gonzalez J.M., Tellechea J.I. EUS hepaticogastrostomy for bilioenteric anastomotic strictures: A permanent access for repeated ambulatory dilations? Results from a pilot study. Endosc Int Open. 2016;4:E461-E465. 4